Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 34 papers were listed this time. Here's a few in our areas of research interest:
Refaat T, Choi M, Gaber G, et al. Markov Model and Cost-Effectiveness Analysis of Bevacizumab in HER2-Negative Metastatic Breast Cancer. Am J Clin Oncol. 2013 Feb 5. [Epub ahead of print] PubMed PMID: 23388565.
Hiligsmann M, Ben Sedrine W, Bruyère O, et al. Cost-effectiveness of strontium ranelate in the treatment of male osteoporosis. Osteoporos Int. 2013 Feb 1. [Epub ahead of print] PubMed PMID: 23371359.
Nshimyumukiza L, Durand A, Gagnon M, et al. An economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures. J Bone Miner Res. 2013 Feb;28(2):383-94. PubMed PMID: 22991210.
photo credit: Images_of_Money via Flickr Creative Commons